Clinical Trial Update: An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD) [Phase 1]

View source ↗

Summary

Reports completion of a Phase 1 exploratory trial of LEO 32731 Cream in adults with mild to moderate atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• LEO 32731 Cream

Snippet

Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 1 | Status: COMPLETED